Clinical Trial of the Efficacy and Safety of AC0010 in the Treatment of EGFR T790M Patients With Advanded NSCLC

NCT03300115 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

222

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Non-small Cell Lung Cancer

Interventions

DRUG: AC0010

Sponsor

Hangzhou ACEA Pharmaceutical Research Co., Ltd.

Collaborators

[object Object]